TY - JOUR A1 - Musnier, B. A1 - Wegner, Karl David A1 - Comby-Zerbino, C. A1 - Trouillet, V. A1 - Jourdan, M. A1 - Häusler, I. A1 - Antoine, R. A1 - Coll, J.-L. A1 - Resch-Genger, Ute A1 - Le Guevel, X. T1 - High photoluminescence of shortwave infrared-emitting anisotropic surface charged gold nanoclusters N2 - Incorporating anisotropic surface charges on atomically precise gold nanoclusters (Au NCs) led to a strong absorption in the nearinfrared region and could enable the formation of self-assembled Au NCs xhibiting an intense absorption band at ∼1000 nm. This surface modification showed a striking enhancement of the photoluminescence in the Shortwave Infrared (SWIR) region with a quantum yield as high as 6.1% in water. KW - Gold nanoclusters KW - SWIR photoluminescence KW - Self-assembly PY - 2019 U6 - https://doi.org/10.1039/C9NR04120F VL - 11 IS - 25 SP - 12092 EP - 12096 PB - Royal Society of Chemistry AN - OPUS4-48305 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Yu, Z. A1 - Musnier, B. A1 - Wegner, Karl David A1 - Henry, M. A1 - Chovelon, B. A1 - Desroches-Castan, A. A1 - Fertin, A. A1 - Resch-Genger, Ute A1 - Bailly, S. A1 - Coll, J.-L. A1 - Usson, Y, A1 - Josserand, V. A1 - Le Gúevel, X. T1 - High-Resolution Shortwave Infrared Imaging of Vascular Disorders Using Gold Nanoclusters N2 - We synthesized a generation of water-soluble, atomically precise gold nanoclusters (Au NCs) with anisotropic Surface containing a short dithiol pegylated chain (AuMHA/TDT). The AuMHA/TDT exhibit a high brightness (QY ∼ 6%) in the shortwave infrared (SWIR) spectrum with a detection above 1250 nm. Furthermore, they show an extended half-life in blood (t1/2ß = 19.54 ± 0.05 h) and a very weak accumulation in organs. We also developed a non-invasive, whole-body vascular imaging system in the SWIR window with high-resolution, benefiting from a series of Monte Carlo image processing. The imaging process enabled to improve contrast by 1 order of magnitude and enhance the spatial Resolution by 59%. After systemic administration of these nanoprobes in mice, we can quantify vessel complexity in depth (>4 mm), allowing to detect very subtle vascular disorders non-invasively in bone morphogenetic protein 9 (Bmp9)-deficient mice. The combination of these anisotropic surface charged Au NCs plus an improved SWIR imaging device allows a precise mapping at high-resolution and an in depth understanding of the organization of the vascular network in live animals. KW - Nanoparticle KW - Nanosensor KW - Fluorescence KW - Metal cluster KW - NIR KW - SWIR KW - Photophysics KW - Ligand KW - Size KW - Surface chemistry KW - Quantum yield KW - Mechanism KW - Lifetime KW - Decay kinetics PY - 2020 U6 - https://doi.org/10.1021/acsnano.0c01174 VL - 14 IS - 4 SP - 4973 EP - 4981 PB - ACS Publication AN - OPUS4-50671 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Godard, A. A1 - Kalot, G. A1 - Pliquett, J. A1 - Busser, B. A1 - Le Guével, X. A1 - Wegner, Karl David A1 - Resch-Genger, Ute A1 - Russelin, Y. A1 - Coll, J.-L. A1 - Denat, F. A1 - Bodio, E. A1 - Goze, C. A1 - Sancey, L. T1 - Water-Soluble Aza-BODIPYs: Biocompatible Organic Dyes for High Contrast In Vivo NIR-II Imaging N2 - A simple NIR-II emitting water-soluble system has been developed and applied in vitro and in vivo. In vitro, the fluorophore quickly accumulated in 2D and 3D cell cultures and rapidly reached the tumor in rodents, showing high NIR-II contrast for up to 1 week. This very efficient probe possesses all the qualities necessary for translation to the clinic as well as for the development of NIR-II emitting materials. KW - Aza-BODIPY KW - NIR-II Imaging KW - In vivo imaging KW - organic dyes KW - SWIR KW - Cancer KW - Fluorescence PY - 2020 U6 - https://doi.org/10.1021/acs.bioconjchem.0c00175 VL - 31 IS - 4 SP - 1088 EP - 1092 PB - ACS Publications AN - OPUS4-50695 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Godard, A. A1 - Kalot, G. A1 - Privat, M. A1 - Bendellaa, M. A1 - Busser, B. A1 - Wegner, Karl David A1 - Denat, F. A1 - Le Guevel, X. A1 - Coll, J.-L. A1 - Paul, C. A1 - Bodio, E. A1 - Goze, C. A1 - Sancey, L. T1 - NIR-II Aza-BODIPY Dyes Bioconjugated to Monoclonal Antibody Trastuzumab for Selective Imaging of HER2-Positive Ovarian Cancer N2 - Using fluorescence-guided surgery (FGS) to cytoreductive surgery helps achieving complete resection of microscopic ovarian tumors. The use of visible and NIR-I fluorophores has led to beneficial results in clinical trials; however, involving NIR-II dyes seems to outperform those benefits due to the deeper tissue imaging and higher signal/noise ratio attained within the NIR-II optical window. In this context, we developed NIR-II emitting dyes targeting human epidermal growth factor receptor 2 (HER2)-positive ovarian tumors by coupling water-soluble NIR-II aza-BODIPY dyes to the FDA-approved anti-HER2 antibody, namely, trastuzumab. These bioconjugated NIR-II-emitting dyes displayed a prolonged stability in serum and a maintained affinity toward HER2 in vitro. We obtained selective targeting of HER2 positive tumors (SKOV-3) in vivo, with a favorable tumor accumulation. We demonstrated the fluorescence properties and the specific HER2 binding of the bioconjugated dyes in vivo and thus their potential for NIR-II FGS in the cancer setting. KW - NIR-II KW - Fluorescent dye KW - In vivo imaging KW - Ovarian cancer KW - Antibody conjuagtes KW - Bioimaging PY - 2023 U6 - https://doi.org/10.1021/acs.jmedchem.3c00100 SN - 0022-2623 VL - 66 IS - 7 SP - 5185 EP - 5195 PB - ACS Publications AN - OPUS4-57293 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER - TY - JOUR A1 - Mohammad, W. A1 - Wegner, Karl David A1 - Comby-Zerbino, C. A1 - Trouillet, V. A1 - Ogayer, M. P. A1 - Coll, J.-L. A1 - Marin, R. A1 - Jaque Garcia, D. A1 - Resch-Genger, Ute A1 - Antoine, R. A1 - Le Guevel, X. T1 - Enhanced brightness of ultra-small gold nanoparticles in the second biological window through thiol ligand shell control N2 - Gold-based nanoparticles below 2 nm in size are promising as luminescent probes for in vivo bioimaging, owing to their brightness and rapid renal clearance. However, their use as contrast agents in the near-infrared II (NIR-II, 1000–1700 nm) range remains challenging due to their low photoluminescence (PL) quantum yield. To address this, PL enhancement can be achieved by either rigidifying the ligand-shell structure or increasing the size of the ligand shell. In this study, we synthesized ultra-small gold nanoparticles stabilized by co-ligands, namely monothiol and short dithiol molecules. By precisely controlling the amount of reducing agent used during particle preparation, we successfully modulated the physicochemical properties of the co-ligand shell, including its size, composition, and structure. Consequently, we achieved a remarkable 60-fold increase in the absorption cross-section at 990 nm while maintaining the small size of the 1.5-nm metal core. The analytical and optical characterization of our thiol-capped gold nanoparticles indicates that the ligand shell size is governed by the quantity of the reducing agent, which, in turn, impacts the balance between radiative and non-radiative processes, thereby influencing the PL quantum yield. KW - Gold nanocluster KW - NIR-II fluorescence KW - SWIR KW - Nanomaterial design KW - Calibrated fluorescence measurements PY - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:b43-588117 SN - 2050-7526 VL - 11 IS - 42 SP - 14714 EP - 14724 PB - Royal Society of Chemistry (RSC) AN - OPUS4-58811 LA - eng AD - Bundesanstalt fuer Materialforschung und -pruefung (BAM), Berlin, Germany ER -